Scientific Expertise Across the Bioprocess Lifecycle

Merging Design, Engineering, and Analytics for Bioprocess Innovation.

Therapy developers must translate complex biological concepts into scalable manufacturing processes.

Technology and material innovators create the tools and materials that make these processes possible.

 

At bespark*bio, we support both sides of this ecosystem.

Cell Line Development

Host system & platform selection

Cell line
development

Media selection & optimization

Process Development

CMC strategy & roadmaps

Process development & optimization

Tech transfer & GMP support

Analytical Development

Analytical
strategy

Method
development

Testing & product characterization

Product Validation

Independent application data

Performance verification

Comparability & feasibility studies

Cell Line Development

Cell Line Development

Building the Biological Foundation for Robust Manufacturing.

Manufacturing performance starts with the biological production system. Host cell lines determine productivity, product quality, stability and scalability.

We design and optimize production cell systems tailored to your therapeutic modality.

Manufacturing performance starts with the biological production system. Host cell lines determine productivity, product quality, stability and scalability.

We design and optimize production cell systems tailored to your therapeutic modality.

Selection of suitable host cell expression systems

Establishment of stable production cell lines (mammalian, insect, primary cell lines)

Media screening, selection & optimization

Optimization of expression performance and productivity

Evaluation of cell line stability and manufacturability

Viral vector engineering across DNA-, RNA-, and baculovirus-based systems

Process Development

Process Development

Designing Scalable Manufacturing Processes.

Therapeutic excellence must be matched by manufacturing excellence.

We design, develop, and optimize processes that enable reliable production, efficient scale-up and strong product quality control.

Therapeutic excellence must be matched by manufacturing excellence.

We design, develop, and optimize processes that enable reliable production, efficient scale-up and strong product quality control.

Strategy development, CMC roadmaps & risk assessment

Upstream, downstream and end-to-end process development

Process optimization and troubleshooting

Identification of critical process parameters and design space

Hybrid modeling, machine learning, and digital twin simulation

Predictive scale-down model development

CDMO selection & technology transfer preparation

Manufacturing oversight and on-site support

Analytical Development

Analytical Development

Understanding Process and Product Quality.

Reliable manufacturing requires a deep understanding OF BOTH the production process and the therapeutic product. 

We develop and apply analytical methods for robust process control and regulatory readiness.

Reliable manufacturing requires a deep understanding OF BOTH the production process and the therapeutic product. 

We develop and apply analytical methods for robust process control and regulatory readiness.

Analytical method development

Product characterization

Process characterization

Identification of critical quality attributes

Comparability assessments

Stability studies

Product Validation

Product Validation

Evaluating Technologies and Materials under Real Bioprocess Conditions.

Innovative materials, Process components, and NEW technologies only succeed when their value becomes visible within real manufacturing processes.

We provide independent, scientifically rigorous evaluation of YOUr PROducts.

Innovative materials, Process components, and NEW technologies only succeed when their value becomes visible within real manufacturing processes.

We provide independent, scientifically rigorous evaluation of YOUr PROducts.

Evaluation of materials and technologies within relevant upstream and downstream processes

Benchmarking against established industry standards

Generation of structured performance datasets

Robustness and scalability assessments

Predictive modeling of operating ranges and performance limits

Generation of standardized test materials such as viral seed stocks or cell banks